Medication info
Glimeril Tablet (Glimepiride)

Glimeril Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Aliko Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200300604 · Notified 2003.12.06 · Insurance code 656000020

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering drug to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering drugs. When switching from another oral glucose-lowering drug to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1–2 weeks. The potency and duration of action of the previous drug should be taken into account. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose must be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is used with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Aliko Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used together with diet and exercise to improve blood sugar control in patients with type 2 diabetes. It can also be administered alone, and if blood sugar control is insufficient with oral hypoglycemics alone, it can be used in combination with insulin. Additionally, when blood sugar control is difficult with sulfonylureas or metformin monotherapy, this medication can be used in conjunction with metformin. This helps to manage the patient's blood sugar levels more effectively. This medication is used to improve blood sugar control in type 2 diabetes.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1–2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral glucose-lowering drug to this medicine There is no exact dose equivalence between this medicine and other oral glucose-lowering drugs. When switching from another oral glucose-lowering drug to this medicine, it is advisable to follow the instructions given under Initial dose. That is, start at 1 mg daily and adjust the dose at intervals of 1–2 weeks. The potency and duration of action of the previous drug should be taken into account. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine; regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by immediate intake of sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose must be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, adding metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each drug. However, efforts should be made to determine the minimum effective dose of each drug for blood glucose control. There is a risk of hypoglycemia when this medicine is used with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Additionally, individuals allergic to this medication or sulfonylureas or sulfonamide medications may be at risk if administered. It is also advisable not to use this medication in patients with severe liver or kidney impairment, and it should not be taken by pregnant or nursing women. In cases of severe infections, pre- or post-surgery, or severe trauma, insulin therapy is recommended. Patients with gastrointestinal disorders may have an increased risk of hypoglycemia due to inadequate food absorption, so caution is advised. This medication contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should not take it. During the first week of treatment, the risk of hypoglycemia is high, so blood sugar levels should be monitored carefully. Individuals who are malnourished, have irregular eating patterns, have imbalanced exercise and carbohydrate intake, or experience changes in meal quantities may also face a higher risk of hypoglycemia. Those who frequently consume alcohol or have weak liver or kidney function may be more sensitive to hypoglycemia and should take precautions. Also, elderly patients or those with thyroid, pituitary, or adrenal dysfunction should be cautious of the risk of hypoglycemia. Additionally, when taking this medication with other drugs, interactions may affect blood sugar control, so consulting with a physician is essential. The most common side effect of this medication is hypoglycemia, which may manifest as headaches, severe hunger, nausea, fatigue, confusion, and in severe cases loss of consciousness or seizures. Rarely, there may be visual disturbances, gastrointestinal symptoms, liver dysfunction, blood abnormalities, or allergic reactions, so if any abnormal symptoms appear, it is crucial to inform a doctor immediately. Particularly in cases of severe allergic reactions, such as hives, difficulty breathing, or low blood pressure, the medication should be discontinued immediately, and medical professional consultation is necessary. It is important to take this medication regularly for blood sugar control along with diet, exercise, and weight management. If hypoglycemia symptoms occur, one should promptly consume foods or drinks containing sugar and educate patients and families about hypoglycemia symptoms and treatment methods. When blood sugar control is challenging due to stress situations, surgeries, or infections, insulin therapy may be transitioned. When taking this medication with other drugs that may lower or raise blood sugar levels, it is crucial to inform the medical staff about any concurrent medications. Special attention is needed for potential interactions with beta-blockers, certain antibiotics, antifungals, and steroids. Pregnant or nursing women should not take this medication, and if planning to become pregnant, alternatives such as insulin therapy should be discussed with a physician. The safety and efficacy of this medication have not been established in children, so it is recommended not to be used. In cases of overdose, severe hypoglycemia may occur, so if symptoms are severe, appropriate treatment should be received promptly at a hospital. This medication should be stored out of reach of children, kept in its original container, and not transferred to other containers for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggression, decreased concentration, decreased agility or motivation, depression, confusion, language abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, itching, hives, rash, difficulty breathing, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reaction of the skin, decreased serum sodium concentration, taste disorder, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius to preserve the effectiveness of the medication.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.